Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy

• Published in: Advanced ultrasound in diagnosis and therapy 2020-12, Vol.4 (4), p.297-302
• Main Authors: Yuejin, Wu, MS, Shaobo, Duan, MD, Luwen, Liu, MS, Shuaiyang, Wang, MS, Shuang, Xu, MS, Liuwei, Hao, BS, Lianzhong, Zhang, MD
• Format: Article
• Language: English
• Subjects: hypertrophic obstructive cardiomyopathy|left ventricular hypertrophy|septal ablation
• ISSN: 2576-2516
• DOI: 10.37015/AUDT.2020.200048

For symptomatic hypertrophic obstructive cardiomyopathy (HOCM), how to effectively relieve left ventricular outflow tract obstruction is of great significance. Relying on drugs and double-chamber pacing to reduce left ventricular outflow tract pressure gradient can alleviate symptoms. Methods to reduce the thickness of inter-ventricular septum include myocardial myectomy, percutaneous transluminal septal myocardial ablation, radiofrequency catheter ablation of ventricular tachycardia, and high-intensity focused ultrasound (HIFU) ablation of the ventricular septum that were performed on animal experiments to reduce inter-ventricular septal thickness, and showed significant therapeutic effects. Ultrasound-guided percutaneous intramyocardial septal ablation, as a less invasive and more effective treatment, exhibited great application prospects in reducing the pressure gradient of left ventricular outflow tract. This article reviews the research progress of several ventricular septal ablation techniques for the treatment of HOCM.